Study to collect samples for MIST analysis of Zibotentan and bioavailability of Zibotentan and Dapagliflozin in heatlhy participants

Trial Identifier: D4325C00003
Sponsor:AstraZeneca
NCTID:NCT04991571
Start Date:July 2021
Primary Completion Date: October 2021
Study Completion Date: October 2021
Condition: Chronic Kidney Diseases

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

LanguageDescription
English Version

Trial Locations

CountryLocation
United States of America, MD Brooklyn, MD, United States of America, 21225